Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Medprex
AddedFeb 18, 2024
UpdatedJun 18, 2026
Medprex

Medprex

Medprex: A web-based platform for regional peer review exchanges, based in Joplin, Missouri.

HQ
Joplin, MO, US
Founded
2013
Overview
Compare
Fundraising
Employees

Medprex is a web-based platform focused on facilitating regional peer review exchanges. The company aims to enhance the quality and efficiency of peer reviews in various professional fields by providing a centralized, accessible online platform. Medprex is headquartered in Joplin, Missouri.

Medprex has successfully established itself as a valuable tool for professionals seeking to streamline the peer review process. By leveraging technology, the platform has improved collaboration and feedback mechanisms, contributing to higher standards in peer-reviewed work.

Medprex - Similar Companies

Med Preps logo

Med Preps

Conex Med/Pro Systems logo

Conex Med/Pro Systems

Medplace logo

Medplace

medplace.com

MedClimate logo

MedClimate

Medpharma logo

Medpharma

medpharma.care

MedAux logo

MedAux

Medimetrix Solutions Exchange logo

Medimetrix Solutions Exchange

Medicratic logo

Medicratic

medicratic.com

Medstro logo

Medstro

Prenovo logo

Prenovo

MedStatix logo

MedStatix

medstatix.com

Meddik logo

Meddik

Medzpeed Solutions logo

Medzpeed Solutions

Mediprocity logo

Mediprocity

mediprocity.com

PeerCapsule logo

PeerCapsule

peercapsule.com

Medprex - Quick Facts

Who are Medprex's competitors?

Companies similar to Medprex include Med Preps, Conex Med/Pro Systems, Medplace and MedClimate.

When was Medprex founded?

Medprex was founded in 2013.

Where is Medprex's headquarters located?

Medprex's headquarters is located in Joplin, MO, US.

When was Medprex's last funding round?

Medprex's most recent funding round was for $150k (USD) in January 2013.

How much has Medprex raised to-date?

As of Jan 1, 2013, Medprex has raised a total of $150k (USD).

How many employees does Medprex have?

Medprex has 5 employees as of Feb 4, 2024.

Medprex - Classification

Ownership
  • Private
Technology
  • Cloud
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Peer Review
  • Software
Tags
  • SaaS
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software